Phase
Condition
Coronary Artery Disease
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years.
Patient provides signed written informed consent before any study-specific procedure.
Undergoing coronary angiography, for silent ischemia, stable angina, acute coronarysyndrome, or other acceptable indication per the local standard of care.
Angiographically 40%-90% stenosis present in at least one native coronary artery.
Undergoing physiological assessment for standard clinical or diagnostic indications
Exclusion
Exclusion Criteria:
Aorto-ostial lesion location within 3 mm of the aorta junction (both right and left).
Left main stenosis
Vessel(s) and lesion(s) not amenable for percutaneous coronary intervention (PCI) ,for example diffuse disease.
Saphenous vein graft, chronic total occlusion
Haemodynamic instability at the time of intervention (heart rate<50 beats per minute,systolic blood pressure <90mmHg), balloon pump
Currently participating in another clinical study that interferes with study results.
Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 yearfollowing index procedure.
Any other medical condition that in the opinion of the investigator will interferewith patient safety or study results.
High degree A-V block, sinus node disease.
Asthma/Chronic obstructive pulmonary disease (COPD) with active wheeze
Known hypersensitivity to adenosine
ST-Elevation Myocardial Infarction (STEMI) within 48 hours.
Study Design
Study Description
Connect with a study center
Columbia University
New York, New York 10032
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.